-
1دورية أكاديمية
المؤلفون: Bonnet, Christophe1 (AUTHOR) cbonnet@uliege.be, Dupuis, Jehan2 (AUTHOR) jehan.dupuis@aphp.fr, Tilly, Hervé3 (AUTHOR) herve.tilly@chb.unicancer.fr, Lamy, Thierry4,5 (AUTHOR) thierry.lamy-de-la-chapelle@univ-rennes1.fr, Fruchart, Christophe6 (AUTHOR) christophe.fruchart@ch-dunkerque.fr, le Gouill, Steven7 (AUTHOR) steven.legouill@curie.fr, Thieblemont, Catherine8 (AUTHOR) catherine.thieblemont@aphp.fr, Morschhauser, Franck9 (AUTHOR) franck.morschhauser@chru-lille.fr, Casasnovas, Olivier10 (AUTHOR) olivier.casasnovas@chu-dijon.fr, Bouabdallah, Krimo11 (AUTHOR) krimo.bouabdallah@chu-bordeaux.fr, Ghesquieres, Hervé12 (AUTHOR) herve.ghesquieres@chu-lyon.fr, Van Den Neste, Eric13 (AUTHOR) eric.vandenneste@saintluc.uclouvain.be, André, Marc14 (AUTHOR) marc.andre@chuuclnamur.uclouvain.be, Cartron, Guillaume15 (AUTHOR) g-cartron@chu-montpellier.fr, Salles, Gilles16 (AUTHOR) sallesg@mskcc.org
المصدر: Cancers. Apr2022, Vol. 14 Issue 7, p1761. 14p.
مصطلحات موضوعية: *THERAPEUTIC use of antineoplastic agents, *RITUXIMAB, *DRUG efficacy, *RESEARCH, *COMBINATION drug therapy, *CLINICAL trials, *HETEROCYCLIC compounds, *CANCER chemotherapy, *DEXAMETHASONE, *TREATMENT effectiveness, *CANCER patients, *KIDNEY diseases, *CISPLATIN, *HEMATOLOGIC malignancies, *LYMPHOMAS, *CYTARABINE, *OXALIPLATIN, *IMMUNOTHERAPY, *DRUG toxicity, *EVALUATION
-
2دورية أكاديمية
المؤلفون: Aussedat, Guillaume1 (AUTHOR), Maucort-Boulch, Delphine2,3 (AUTHOR), Rey, Philippe4 (AUTHOR), Safar, Violaine1 (AUTHOR), Karlin, Lionel1 (AUTHOR), Elsensohn, Mad Helenie2,3 (AUTHOR), Bachy, Emmanuel1 (AUTHOR), Lebras, Laure4 (AUTHOR), Favier, Bertrand5 (AUTHOR), Vantard, Nicolas6 (AUTHOR), Ghergus, Dana1 (AUTHOR), Golfier, Camille1 (AUTHOR), Sesques, Pierre1 (AUTHOR), Lazareth, Anne1 (AUTHOR), Lequeu, Hélène1 (AUTHOR), Ferrant, Emmanuelle1 (AUTHOR), Salles, Gilles1 (AUTHOR), Nicolas-Virelizier, Emmanuelle4 (AUTHOR), Ghesquieres, Hervé1 (AUTHOR)
المصدر: Leukemia & Lymphoma. Mar2022, Vol. 63 Issue 3, p599-607. 9p.
مصطلحات موضوعية: *DIFFUSE large B-cell lymphomas, *IFOSFAMIDE, *RITUXIMAB, *STEM cell transplantation, *ETOPOSIDE
-
3دورية أكاديمية
المؤلفون: Ribrag, Vincent1 vincent.ribrag@gustaveroussy.fr, Koscielny, Serge2,3, Bosq, Jacques4, Leguay, Thibaut5, Casasnovas, Olivier6, Fornecker, Luc-Mathieu7, Recher, Christian8, Ghesquieres, Hervé9, Morschhauser, Franck10, Girault, Stéphane11, Le Gouill, Steven12, Ojeda-Uribe, Mario13, Mariette, Clara14, Cornillon, Jerome15, Cartron, Guillaume16, Verge, Veronique17, Chassagne-Clément, Catherine18, Dombret, Hervé19, Coiffier, Bertrand20, Lamy, Thierry21,22
المصدر: Lancet. 6/11/2016, Vol. 387 Issue 10036, p2402-2411. 10p.
مصطلحات موضوعية: *RITUXIMAB, *PHYSIOLOGICAL effects of chemotherapy, *BURKITT'S lymphoma, *ANTINEOPLASTIC agents, *DRUG side effects, *THERAPEUTICS, *B cell lymphoma, *CLINICAL trials, *COMPARATIVE studies, *DOXORUBICIN, *DRUG administration, *HYDROCORTISONE, *INTRAVENOUS injections, *RESEARCH methodology, *MEDICAL cooperation, *METHOTREXATE, *PREDNISONE, *RESEARCH, *TUMOR classification, *VINCRISTINE, *EVALUATION research, *RANDOMIZED controlled trials, *TREATMENT effectiveness, *PROPORTIONAL hazards models, *PATIENT selection, *CYCLOPHOSPHAMIDE, *CYTARABINE, *METHYLPREDNISOLONE, *ODDS ratio, *DIAGNOSIS, BONE marrow cancer, CENTRAL nervous system tumors
مصطلحات جغرافية: FRANCE
-
4دورية أكاديمية
المؤلفون: Sarkozy, Clémentine1,2, Seymour, John Francis3,4, Ferme, Christophe5, Caballero, Dolores6, Ghesquieres, Hervé7, Leppa, Sirpa8,9, Delarue, Richard10,11, Moller Pedersen, Lars12, Mounier, Christiane13, Gomes Da Silva, Maria14, Chassagne-Clement, Catherine7, Maerevoet, Marie15,16, Salles, Gilles1,17 gilles.salles@chu-lyon.fr
المصدر: Blood. 4/24/2014, Vol. 123 Issue 17, p2740-2742. 2p.
مصطلحات موضوعية: *RITUXIMAB, *LYMPHOMAS, *DRUG efficacy, *PATIENTS